Bret Jensen
Contributor since: 2010
Company: The Biotech Forum
Articles
Checking In On Catalyst Biosciences
Today, 11:56 AM CBIO1 Comment
Reassessing Heron Therapeutics
Today, 11:08 AM HRTX4 Comments
A Recommendation For Rigel Pharmaceuticals
Sun, May 16 RIGL4 Comments
Our Take On TCR2 Therapeutics
Fri, May 14 TCRR5 Comments
Inflation Fears Are Just Beginning
Thu, May 13 GORO, TBT, SPY98 Comments
Post Earnings Assessment On ANI Pharmaceuticals
Tue, May 11 ANIP5 Comments
Dynavax Technologies: An Emerging Covid19 Dynamo
Mon, May 10 DVAX26 Comments
Checking In On Cortexyme
Thu, May 6 CRTX8 Comments
Gold Resource Corporation: A $3 Inflation Play
Wed, May 5 GORO21 Comments
The 'Big Apple' Exodus
Fri, Apr. 30 HOFT, HVT, LGIH49 Comments
A Look At Limoneira
Thu, Apr. 29 LMNR9 Comments
Aptose Biosciences: An Assessment
Tue, Apr. 27 APTO6 Comments
Where All The Uber Drivers Went!
Sun, Apr. 25 57 Comments
Inflation Feels Much Higher Than Headline Numbers
Mon, Apr. 19 HD, BZH, IVOL70 Comments
Taking Our First Look At Tricida
Fri, Apr. 16 TCDA6 Comments
Circling Back On Acadia Pharmaceuticals
Thu, Apr. 15 ACAD16 Comments
Our Move On Mereo BioPharma
Thu, Apr. 15 MREO4 Comments
Circling Back On Adamas Pharmaceuticals
Wed, Apr. 14 ADMS
Our First Look At Entera Bio
Tue, Apr. 13 ENTX1 Comment
Circling Back On Akari Therapeutics
Tue, Apr. 13 AKTX6 Comments
CorMedix: CRL Resolution Likely
Sat, Apr. 10 CRMD12 Comments
Our Current Take On Biohaven Pharmaceutical
Thu, Apr. 8 BHVN6 Comments
Checking In On Cyclacel Pharmaceuticals
Tue, Apr. 6 CYCC4 Comments
Assessing Amicus Therapeutics After Trial Results
Mon, Apr. 5 FOLD3 Comments
Vectoring Back In On Vanda Pharmaceuticals
Sun, Apr. 4 VNDA3 Comments
Checking Back In On Kamada
Thu, Apr. 1 KMDA4 Comments
Our Take On Molecular Templates
Wed, Mar. 31 MTEM3 Comments
The Right Call On Frustrating Flexion Therapeutics
Mon, Mar. 29 FLXN7 Comments
Checking Back In On Cidara Therapeutics
Sat, Mar. 27 CDTX4 Comments
The Prognosis For Precision BioSciences
Thu, Mar. 25 DTIL25 Comments
Sizing Up Greenhill & Co.
Wed, Mar. 24 GHL2 Comments
An Assessment On Aptevo Therapeutics
Wed, Mar. 24 APVO8 Comments